Asia Pacific mHealth Market Forecast to 2028 - COVID-19 Impact and Regional Analysis– by Service Type (Remote Monitoring, Diagnosis, Treatment, Health Support, Fitness & Wellness, and Others), Devices Type (Insulin Pimp, BP Monitor, Glucose Monitor, Personal Pulse Oximeter, and Others), and End User Type (Mobile Operators, Devices Vendors, Health Providers, and Others)

The Asia Pacific mHealth market is expected to reach US$ 98,165.95 million by 2028 from US$ 16,477.42 million in 2021; it is estimated to grow at a CAGR of 29.0% from 2021 to 2028.

The emerging markets in regions such as the Asia Pacific are creating significant opportunities for the key market players to expand their businesses. The majority of players concentrate on developing markets, such as India and China, owing to the large population suffering from chronic diseases in these countries. With rising production costs against their practices, healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in a few growing economies are expected to be essential in offering more reliable and profitable growth opportunities for the major players to expand their industry and geographic scope. Advancements in home diagnostics increased the demand for telemedicine in the healthcare market, encouraging the introduction of more analytical systems and facilitating the shift toward mHealth. Emerging countries have new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics. Hence, healthcare companies can target patients or consumers in developing nations. The Asia Pacific mHealth market is expected to grow at a good CAGR during the forecast period.

Asia Pacific mHealth Revenue and Forecast to 2028 (US$ Million)

Asia Pacific mHealth Market Segmentation

The Asia Pacific mHealth market is segmented into service type, devices type, end user type, and country. Based on service type, the Asia Pacific mHealth market is segmented into remote monitoring, diagnosis, treatment, health support, fitness & wellness, and others. The remote monitoring segment dominated the Asia Pacific mHealth market in 2020. Based on devices type, the Asia Pacific mHealth market is divided into insulin pimp, bp monitor, glucose monitor, personal pulse oximeter, and others. The insulin pimp segment dominated the Asia Pacific mHealth market in 2020. Based on end user type, the Asia Pacific mHealth market is categorized into mobile operators, devices vendors, health providers, and others. The mobile operators dominated the Asia Pacific mHealth market in 2020. Based on country, the Asia Pacific mHealth market is segmented into China, Japan, India, South Korea, Australia, Indonesia, and the rest of Asia Pacific. China dominated the Asia Pacific mHealth market in 2020.

SehatQ; Good Doctor; Klikdockter.com; Alodokter; Hello Health Group Pte.Ltd (Hello Sehat); RS.Awal Bros; Smarter Health Pte.Ltd; SILOAM HOSPITAL Group; DockterSehat; Koninklijeke Phillips N.V; Medtronic; Boston Scientific Corporation; althenahealth,Inc; CISCO SYSTEM, Inc; OMRON Corporation; and Masimo are among the leading companies in Asia Pacific mHealth market.

1.HALDOC.

2. SehatQ.

3.Good Doctor.

4.Klikdockter.com.

5.Alodokter.

6.Hello Health Group Pte.Ltd (Hello Sehat).

7.RS.Awal Bros.

8.Smarter Health Pte.Ltd.

9.SILOAM HOSPITAL Group.

10.DockterSehat.

11.Koninklijeke Phillips N.V.

12.Medtronic.

13.Boston Scientific Corporation.

14.althenahealth,Inc.

15.CISCO SYSTEM,Inc.

16.OMRON Corporation.

17. Masimo.

18. Agamatrix,Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific mHealth market forecast.   
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific mHealth market forecast, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the mHealth, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.